Aspirin may reduce risk of metastases and death in patients with cancer, study findsBMJ 2016; 353 doi: http://dx.doi.org/10.1136/bmj.i2284 (Published 21 April 2016) Cite this as: BMJ 2016;353:i2284
- Susan Mayor
Taking low dose aspirin in addition to treatment for cancer is associated with a 15-20% reduction in mortality and reduced metastatic spread in people with a range of different cancers, a review in PLoS One has shown.1
Researchers looked for published studies involving patients with cancer who took aspirin after diagnosis. They found five randomised trials and 42 observational studies that met their criteria, including 16 of patients with colorectal cancer, 10 of breast cancer, and 10 of prostate cancer mortality. Patients in most of the studies were …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial